Herpes simplex virus type 2 and HIV infection among US military personnel: Implications for health prevention programmes

International Journal of STD and AIDS

Volumn 20, Issue 9, 2009, Pages 634-637

  Bautista, C T ^a   Singer, D E ^a   O'Connell, R J ^a,b   Crum Cianflone, N ^b,c   Agan, B K ^b   Malia, J A ^a   Sanchez, J L ^d   Peel, S A ^a   Michael, N L ^a   Scott, P T ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d WRAIR   (United States)

Author keywords

Co infection; Epidemiology; Herpes; HIV; HSV 2; Military; United States

Indexed keywords

ADOLESCENT; ADULT; ARMY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HERPES GENITALIS; HIV INFECTIONS; HUMANS; MALE; MILITARY PERSONNEL; PREVALENCE; RISK FACTORS;

EID: 69949147936     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008413     Document Type: Article

References (27)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296:964-973 (Pubitemid 44285373)
2. Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-920 (Pubitemid 32378626)
3. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The casual role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill criteria. Sex Transm Dis 1996;23:429-440 (Pubitemid 26313855)
4. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002;16:2425-2430 (Pubitemid 35471690)
5. Freeman EE,Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increasesHIVacquisition inmen andwomen: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83
6. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000;182:1090-1096 (Pubitemid 30736807)
7. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-799 (Pubitemid 46294611)
8. Zuckerman RA, Lucchetti A, Whittington WLH, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007;196:1500-1508
9. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002;186:1718-1725 (Pubitemid 35463503)
10. Bautista CT, Sateren WB, Sanchez JL, et al. HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003). J Acquir Immune Defic Syndr 2006;43:351-355
11. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health 2002;92:1900-1904
12. Crum NF, Wallace MR, Stephan K, et al. Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virus. Sex Transm Dis 2003;30:713-718 (Pubitemid 37087858)
13. Wright J, Albright TS, Gehrich AP, Dunlow SG, Lettieri CF, Buller JL. Sexually transmitted diseases in Operation Iraqi Freedom/Operation Enduring Freedom. Mil Med 2006;171:1024-1026 (Pubitemid 44583091)
14. Centers for Disease Control and Prevention, Division of STD Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1-94
15. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal 2000;14:13-16
16. Lui KJ. Interval estimation of the attributable risk in case-control studies with matched pairs. J Epidemiol Commun Health 2001;55:885-890 (Pubitemid 33097222)
17. Wald A, Link K. Risk of human immunodeficiency virus (HIV) infection in herpes simplex virus type 2 (HSV-2) seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52 (Pubitemid 34043015)
18. Madkan VK, Giancola AA, Sra KK, Tyring SK. Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases. Arch Dermatol 2006;142:365-370
19. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-3106 (Pubitemid 32578207)
20. Jennifer S, Smith N, Robinson J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28
21. Heintzman J, Rugge B, Judkins DZ, Julka M, Clinical inquiries. What''s the best test for HSV-2 after exposure? J Fam Pract 2007;56:221-222
22. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003;187:1513-1521 (Pubitemid 36578957)
23. Rana RK, Pimenta JM, Rosenberg DM, et al. Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes. Sex Transm Infect 2006;82:69-74
24. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20 (Pubitemid 38032179)
25. Romanowski B, Marina RB, Roberts JN, Valtrex HS230017 Study Group. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. Sex Transm Dis 2003;30:226-231
26. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:2109-2119 (Pubitemid 351902179)
27. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008;358:1560-1571